Regulation on a derogation from Regulation (EU) No 1290/2013 of the European Parliament and of the Council laying down the rules for participation and dissemination in "Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020)" with regard to the Innovative Medicines Initiative 2 Joint Undertaking

This procedure establishes a specific exception to the general rules for participation and dissemination within the Horizon 2020 research and innovation programme. It concerns the Innovative Medicines Initiative 2 Joint Undertaking, allowing it to operate under tailored conditions.

This affects entities participating in or benefiting from the Innovative Medicines Initiative 2 Joint Undertaking. It ensures flexibility in how research results are shared and how partners engage within this specific public-private partnership.